Succinic Acid

Succinic Acid

SCHEMBL25391900

CC(CCCO)C(=O)O.O=C(O)CCC(=O)O

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1CDK4CDK6CHRM2CHRM3DPP4DRD2DRD3DRD4EGFRHRH1HTR1BHTR1DHTR1FHTR2AHTR2CHTR4SLC6A2SLC6A4

The experimentally established mechanism targets of Succinic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.64
LTA4H P09960 1/20 0.50
BLM P54132 1/20 0.50
CAMK2A Q9UQM7 1/20 0.48
GABRR1 P24046 2/20 0.46
GPR84 Q9NQS5 1/20 0.44
FFAR1 O14842 1/20 0.44
FFAR4 Q5NUL3 1/20 0.44
ACE2 Q9BYF1 1/20 0.42
GABRP O00591 2/20 0.41
GABRD O14764 2/20 0.41
GABRA1 P14867 2/20 0.41
GABRB1 P18505 2/20 0.41
GABRG2 P18507 2/20 0.41
GABRB3 P28472 2/20 0.41
GABRA5 P31644 2/20 0.41
GABRA3 P34903 2/20 0.41
GABRA2 P47869 2/20 0.41
GABRB2 P47870 2/20 0.41
GABRA4 P48169 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1859719 0.91
SCHEMBL13554886 0.84 BLM (0.56) CYP1A2LTA4HBLMGABRR1GPR84
SCHEMBL148481 0.84 CYP1A2 (0.73) CYP1A2LTA4HBLMGABRR1FFAR1
SCHEMBL18317937 0.84 CYP1A2 (0.73) CYP1A2LTA4HBLMGABRR1FFAR1
SCHEMBL279916 0.84 CYP1A2 (0.73) CYP1A2LTA4HBLMGABRR1FFAR1
SCHEMBL422422 0.84 BLM (0.56) CYP1A2LTA4HBLMGABRR1GPR84
Ethylene Glycol SCHEMBL27489872 0.83 CYP1A2 (0.59) CYP1A2LTA4HBLMGPR84FFAR1
1,6-Hexanediol SCHEMBL27541076 0.83 FFAR1 (0.57) CYP1A2LTA4HBLMCAMK2AGPR84
SCHEMBL15228384 0.83 LTA4H (0.50) CYP1A2LTA4HBLMGABRR1GPR84
SCHEMBL11453210 0.82 CYP1A2 (0.70) CYP1A2LTA4HBLMGABRR1FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023171894-A1 PHARMACEUTICAL COMPOSITION INCLUDING DOCETAXEL OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND PREPARATION METHOD THEREFOR 주식회사 위바이오트리 2023-09-14 WO disclosed
CN-106459049-A Tyrosine kinase inhibitors 普林斯匹亚生物制药公司 2017-02-22 CN disclosed
CN-101496794-B Enteric long-acting coating core and medicament dosage form and method for producing the same HUANENG PHARMACEUTICALS CO LTD 2013-12-11 CN disclosed
CN-102908331-A Duloxetine hydrochloride enteric capsules and preparation method thereof ZHEJIANG JIUZHOU PHARMACEUTICAL TECHNOLOGY CO LTD 2013-02-06 CN disclosed
CN-101496794-A Enteric long-acting coated core and pharmaceutical dosage form and method for producing the same TAIWAN BIOTECHNOLOGY CO LTD (CN) 2009-08-05 CN disclosed
CN-100362997-C Enteric coated table of duloxetine, and preparation method SHANGHAI INST OF MEDICINE IND (CN) 2008-01-23 CN disclosed
CN-100362996-C Duloxetine enteric coated tiny pill capsule, and preparation method SHANGHAI INST OF MEDICINE IND (CN) 2008-01-23 CN disclosed
CN-1759830-A Enteric coated table of duloxetine, and preparation method SHANGHAI INST OF MEDICINE IND (CN) 2006-04-19 CN disclosed
CN-1759829-A Duloxetine enteric coated tiny pill capsule, and preparation method SHANGHAI INST OF MEDICINE IND (CN) 2006-04-19 CN disclosed